| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8311402 | Clinica Chimica Acta | 2015 | 6 Pages |
Abstract
In patients with FCHL apo CIII, apo AII and adiponectin are major novel factors determining the VLDL particle composition. However, such factors do not explain apo B-containing particles.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Ivette Cruz-Bautista, Roopa Mehta, Javier Cabiedes, Cristina GarcÃa-Ulloa, Luz Elizabeth Guillen-Pineda, Paloma Almeda-Valdés, Daniel Cuevas-Ramos, Carlos A. Aguilar-Salinas,